Prognostic usefulness of free fatty acids in patients with stable coronary heart disease

American Journal of Cardiology

Volumn 108, Issue 4, 2011, Pages 508-513

  Breitling, Lutz P ^a   Rothenbacher, Dietrich ^a,b   Grandi, Norma C ^a   März, Winfried ^c   Brenner, Hermann ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b UNIVERSITY OF ULM   (Germany)

^c SYNLAB ACADEMY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

FATTY ACID;

ACUTE CORONARY SYNDROME; ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; FATTY ACID BLOOD LEVEL; FEMALE; GERMANY; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTICENTER STUDY; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; REHABILITATION CARE; STABLE CORONARY HEART DISEASE; STROKE;

ADULT; AGED; CORONARY DISEASE; FATTY ACIDS, NONESTERIFIED; FEMALE; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; RISK ASSESSMENT; RISK FACTORS;

EID: 79960898780     PISSN: 00029149     EISSN: 18791913     Source Type: Journal    
DOI: 10.1016/j.amjcard.2011.03.076     Document Type: Article

References (26)

1. Pilz S, Marz W. Free fatty acids as a cardiovascular risk factor. Clin Chem Lab Med 2008;46:429-434. (Pubitemid 351820374)
2. Boden G. Interaction between free fatty acids and glucose metabolism. Curr Opin Clin Nutr Metab Care 2002;5:545-549. (Pubitemid 40684651)
3. Pilz S, Scharnagl H, Tiran B, Wellnitz B, Seelhorst U, Boehm BO, Marz W. Elevated plasma free fatty acids predict sudden cardiac death: a 6.85-year follow-up of 3315 patients after coronary angiography. Eur Heart J 2007;28:2763-2769. (Pubitemid 350135527)
4. Arii K, Suehiro T, Yamamoto M, Ito H, Hashimoto K. Suppression of plasma cholesteryl ester transfer protein activity in acute hyperinsulinemia and effect of plasma nonesterified fatty acid. Metabolism 1997;46:1166 -1170.
5. Mathew M, Tay E, Cusi K. Elevated plasma free fatty acids increase cardiovascular risk by inducing plasma biomarkers of endothelial activation, myeloperoxidase and PAI-1 in healthy subjects. Cardiovasc Diabetol 2010;9:9.
6. Steinberg HO, Tarshoby M, Monestel R, Hook G, Cronin J, Johnson A, Bayazeed B, Baron AD. Elevated circulating free fatty acid levels impair endothelium-dependent vasodilation. J Clin Invest 1997;100: 1230-1239. (Pubitemid 27386309)
7. Carlsson M, Wessman Y, Almgren P, Groop L. High levels of nonesterified fatty acids are associated with increased familial risk of cardiovascular disease. Arterioscler Thromb Vasc Biol 2000;20:1588-1594. (Pubitemid 30353892)
8. Breitling LP, Grandi NC, Hahmann H, Wusten B, Rothenbacher D, Brenner H. Gamma-glutamyltransferase and prognosis in patients with stable coronary heart disease followed over 8 years. Atherosclerosis 2010;210:649-655.
9. Rothenbacher D, Koenig W, Brenner H. Comparison of N-terminal pro-B-natriuretic peptide, C-reactive protein, and creatinine clearance for prognosis in patients with known coronary heart disease. Arch Intern Med 2006;166:2455-2460. (Pubitemid 44913229)
10. Apple FS, Wu AH, Mair J, Ravkilde J, Panteghini M, Tate J, Pagani F, Christenson RH, Mockel M, Danne O, Jaffe AS. Future biomarkers for detection of ischemia and risk stratification in acute coronary syndrome. Clin Chem 2005;51:810-824. (Pubitemid 40577917)
11. Kleinfeld AM, Prothro D, Brown DL, Davis RC, Richieri GV, DeMaria A. Increases in serum unbound free fatty acid levels following coronary angioplasty. Am J Cardiol 1996;78:1350-1354. (Pubitemid 126657226)
12. Roos M, von Eynatten M, Heemann U, Rothenbacher D, Brenner H, Breitling LP. Serum fetuin-A, cardiovascular risk factors, and six-year follow-up outcome in patients with coronary heart disease. Am J Cardiol 2010;105:1666-1672.
13. Duwensee K, Breitling LP, Tancevski I, Rothenbacher D, Demetz E, Patsch JR, Ritsch A, Eller P, Brenner H. Cholesteryl ester transfer protein in patients with coronary heart disease. Eur J Clin Invest 2010;40:616-622.
14. von Eynatten M, Hamann A, Twardella D, Nawroth PP, Brenner H, Rothenbacher D. Relationship of adiponectin with markers of systemic inflammation, atherogenic dyslipidemia, and heart failure in patients with coronary heart disease. Clin Chem 2006;52:853-859.
15. Koenig W, Vossen CY, Mallat Z, Brenner H, Benessiano J, Rothenbacher D. Association between type II secretory phospholipase A2 plasma concentrations and activity and cardiovascular events in patients with coronary heart disease. Eur Heart J 2009;30:2742-2748.
16. Pilz S, Scharnagl H, Tiran B, Seelhorst U, Wellnitz B, Boehm BO, Schaefer JR, Marz W. Free fatty acids are independently associated with all-cause and cardiovascular mortality in subjects with coronary artery disease. J Clin Endocrinol Metab 2006;91:2542-2547. (Pubitemid 44024615)
17. Hosmer DW, Lemeshow S. Applied Survival Analysis: Regression Modeling of Time to Event Data. New York, New York: John Wiley, 1999.
18. Desquilbet L, Mariotti F. Dose-response analyses using restricted cubic spline functions in public health research. Stat Med 2010;29: 1037-1057.
19. Twardella D, Rothenbacher D, Hahmann H, Wusten B, Brenner H. The underestimated impact of smoking and smoking cessation on the risk of secondary cardiovascular disease events in patients with stable coronary heart disease: prospective cohort study. J Am Coll Cardiol 2006;47:887-889. (Pubitemid 43243119)
20. Hellerstein MK, Benowitz NL, Neese RA, Schwartz JM, Hoh R, Jacob P III, Hsieh J, Faix D. Effects of cigarette smoking and its cessation on lipid metabolism and energy expenditure in heavy smokers. J Clin Invest 1994;93:265-272. (Pubitemid 24030845)
21. Richieri GV, Anel A, Kleinfeld AM. Interactions of long-chain fatty acids and albumin: determination of free fatty acid levels using the fluorescent probe ADIFAB. Biochemistry 1993;32:7574-7580. (Pubitemid 23232334)
22. Jouven X, Charles MA, Desnos M, Ducimetiere P. Circulating nonesterified fatty acid level as a predictive risk factor for sudden death in the population. Circulation 2001;104:756-761. (Pubitemid 32762671)
23. Charles MA, Fontbonne A, Thibult N, Claude JR, Warnet JM, Rosselin G, Ducimetiere P, Eschwege E. High plasma nonesterified fatty acids are predictive of cancer mortality but not of coronary heart disease mortality: results from the Paris Prospective Study. Am J Epidemiol 2001;153:292-298. (Pubitemid 32958654)
24. Forsblom CM, Sane T, Groop PH, Totterman KJ, Kallio M, Saloranta C, Laasonen L, Summanen P, Lepantalo M, Laatikainen L, Matikainen E, Teppo AM, Koskimies S, Groop L. Risk factors for mortality in Type II (non-insulin- dependent) diabetes: evidence of a role for neuropathy and a protective effect of HLA-DR4. Diabetologia 1998;41: 1253-1262. (Pubitemid 28488750)
25. Pirro M, Mauriege P, Tchernof A, Cantin B, Dagenais GR, Despres JP, Lamarche B. Plasma free fatty acid levels and the risk of ischemic heart disease in men: prospective results from the Quebec Cardiovascular Study. Atherosclerosis 2002;160:377-384. (Pubitemid 34159331)
26. Kupper-Nybelen J, Rothenbacher D, Hahmann H, Wusten B, Brenner H. Changes of risk factors in patients with coronary heart disease after in-patient rehabilitation [article in German]. Dtsch Med Wochenschr 2003;128:1525-1530. (Pubitemid 36871754)